145 related articles for article (PubMed ID: 34370841)
21. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
22. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
23. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues.
Morani A; Warner M; Gustafsson JA
J Intern Med; 2008 Aug; 264(2):128-42. PubMed ID: 18513343
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.
Ronghe A; Chatterjee A; Singh B; Dandawate P; Murphy L; Bhat NK; Padhye S; Bhat HK
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():500-12. PubMed ID: 25242450
[TBL] [Abstract][Full Text] [Related]
25. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
[TBL] [Abstract][Full Text] [Related]
26. The role of estrogen receptor-β in breast cancer.
Murphy LC; Leygue E
Semin Reprod Med; 2012 Jan; 30(1):5-13. PubMed ID: 22271289
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis.
Trukhacheva E; Lin Z; Reierstad S; Cheng YH; Milad M; Bulun SE
J Clin Endocrinol Metab; 2009 Feb; 94(2):615-22. PubMed ID: 19001520
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Omoto Y; Iwase H
Cancer Sci; 2015 Apr; 106(4):337-43. PubMed ID: 25611678
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
Skliris GP; Leygue E; Watson PH; Murphy LC
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
[TBL] [Abstract][Full Text] [Related]
32. [Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].
Mitter D; Ortmann O; Treeck O
Zentralbl Gynakol; 2005 Aug; 127(4):228-34. PubMed ID: 16037904
[TBL] [Abstract][Full Text] [Related]
33. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
34. ERbeta in breast cancer--onlooker, passive player, or active protector?
Fox EM; Davis RJ; Shupnik MA
Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
[TBL] [Abstract][Full Text] [Related]
35. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor-beta and breast cancer: translating biology into clinical practice.
Leung YK; Lee MT; Lam HM; Tarapore P; Ho SM
Steroids; 2012 Jun; 77(7):727-37. PubMed ID: 22465878
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
[TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
39. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type.
Lima F; Vico L; Lafage-Proust MH; van der Saag P; Alexandre C; Thomas T
Bone; 2004 Nov; 35(5):1127-35. PubMed ID: 15542038
[TBL] [Abstract][Full Text] [Related]
40. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
